Chimeric Therapeutics Ltd

CHM•Health Care•Biotechnology•Last updated: Dec 25

About

Chimeric Therapeutics Ltd is a biotechnology company focused on the development of cell therapies for cancer treatment. The company specializes in chimeric antigen receptor T cell (CAR-T) therapies, aiming to harness the immune system to target and destroy cancer cells. Chimeric Therapeutics is engaged in the research and development of its proprietary CAR-T platform, with a pipeline that includes therapies for solid tumors and hematological malignancies.

Share Price Chart

Company Details

Sector: Health Care
Industry: Biotechnology
ASX Code: CHM

Related Shares

1AD•Health Care

Adalta Ltd

Biotechnology

1AI•Health Care

Algorae Pharmaceuticals Ltd

Biotechnology

ACW•Health Care

Actinogen Medical Ltd

Biotechnology

AGN•Health Care

Argenica Therapeutics Ltd

Biotechnology

ALA•Health Care

Arovella Therapeutics Ltd

Biotechnology

AN1•Health Care

Anagenics Ltd

Biotechnology

Investor Resources

Investor Relations

Should you buy Chimeric Therapeutics Ltd right now?

While CHM looks interesting right now, our experts have just put together a full report on the ultimate ASX investment portfolio - designed for growth and passive income.

Join the Rask weekly investment newsletter to get the names, right now